202 related articles for article (PubMed ID: 37680719)
1. Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators.
Dahlke P; Peltner LK; Jordan PM; Werz O
Front Pharmacol; 2023; 14():1219160. PubMed ID: 37680719
[TBL] [Abstract][Full Text] [Related]
2. Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201.
Kretzer C; Jordan PM; Bilancia R; Rossi A; Gür Maz T; Banoglu E; Schubert US; Werz O
J Inflamm Res; 2022; 15():911-925. PubMed ID: 35173459
[TBL] [Abstract][Full Text] [Related]
3. Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages.
Kretzer C; Jordan PM; Meyer KPL; Hoff D; Werner M; Hofstetter RK; Koeberle A; Cala Peralta A; Viault G; Seraphin D; Richomme P; Helesbeux JJ; Stuppner H; Temml V; Schuster D; Werz O
Biochem Pharmacol; 2022 Jan; 195():114825. PubMed ID: 34762841
[TBL] [Abstract][Full Text] [Related]
4. Formation of lipoxins and resolvins in human leukocytes.
Kahnt AS; Schebb NH; Steinhilber D
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators.
Pace S; Zhang K; Jordan PM; Bilancia R; Wang W; Börner F; Hofstetter RK; Potenza M; Kretzer C; Gerstmeier J; Fischer D; Lorkowski S; Gilbert NC; Newcomer ME; Rossi A; Chen X; Werz O
Pharmacol Res; 2021 May; 167():105556. PubMed ID: 33812006
[TBL] [Abstract][Full Text] [Related]
6. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
7. Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome.
Werner M; Jordan PM; Romp E; Czapka A; Rao Z; Kretzer C; Koeberle A; Garscha U; Pace S; Claesson HE; Serhan CN; Werz O; Gerstmeier J
FASEB J; 2019 May; 33(5):6140-6153. PubMed ID: 30735438
[TBL] [Abstract][Full Text] [Related]
8. On the biosynthesis of specialized pro-resolving mediators in human neutrophils and the influence of cell integrity.
Mainka M; George S; Angioni C; Ebert R; Goebel T; Kampschulte N; Krommes A; Weigert A; Thomas D; Schebb NH; Steinhilber D; Kahnt AS
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Mar; 1867(3):159093. PubMed ID: 34942381
[TBL] [Abstract][Full Text] [Related]
9. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
10. 15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5.
Perry SC; Kalyanaraman C; Tourdot BE; Conrad WS; Akinkugbe O; Freedman JC; Holinstat M; Jacobson MP; Holman TR
J Lipid Res; 2020 Jul; 61(7):1087-1103. PubMed ID: 32404334
[TBL] [Abstract][Full Text] [Related]
11. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Schebb NH; Kühn H; Kahnt AS; Rund KM; O'Donnell VB; Flamand N; Peters-Golden M; Jakobsson PJ; Weylandt KH; Rohwer N; Murphy RC; Geisslinger G; FitzGerald GA; Hanson J; Dahlgren C; Alnouri MW; Offermanns S; Steinhilber D
Front Pharmacol; 2022; 13():838782. PubMed ID: 35308198
[TBL] [Abstract][Full Text] [Related]
12. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP).
Pergola C; Gerstmeier J; Mönch B; Çalışkan B; Luderer S; Weinigel C; Barz D; Maczewsky J; Pace S; Rossi A; Sautebin L; Banoglu E; Werz O
Br J Pharmacol; 2014 Jun; 171(12):3051-64. PubMed ID: 24641614
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators.
Peltner LK; Gluthmann L; Börner F; Pace S; Hoffstetter RK; Kretzer C; Bilancia R; Pollastro F; Koeberle A; Appendino G; Rossi A; Newcomer ME; Gilbert NC; Werz O; Jordan PM
Cell Chem Biol; 2023 Dec; 30(12):1508-1524.e7. PubMed ID: 37647900
[TBL] [Abstract][Full Text] [Related]
14. Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening.
Cerchia C; Küfner L; Werz O; Lavecchia A
Eur J Med Chem; 2024 Jan; 263():115932. PubMed ID: 37976708
[TBL] [Abstract][Full Text] [Related]
15. Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cells.
Nischang V; Witt FM; Börner F; Gomez M; Jordan PM; Werz O
Front Pharmacol; 2023; 14():1332628. PubMed ID: 38239198
[No Abstract] [Full Text] [Related]
16. Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: A promising pharmacological strategy for anti-inflammatory therapy.
Gerstmeier J; Kretzer C; Di Micco S; Miek L; Butschek H; Cantone V; Bilancia R; Rizza R; Troisi F; Cardullo N; Tringali C; Ialenti A; Rossi A; Bifulco G; Werz O; Pace S
Biochem Pharmacol; 2019 Jul; 165():263-274. PubMed ID: 30836057
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein.
Lehmann C; Homann J; Ball AK; Blöcher R; Kleinschmidt TK; Basavarajappa D; Angioni C; Ferreirós N; Häfner AK; Rådmark O; Proschak E; Haeggström JZ; Geisslinger G; Parnham MJ; Steinhilber D; Kahnt AS
FASEB J; 2015 Dec; 29(12):5029-43. PubMed ID: 26289316
[TBL] [Abstract][Full Text] [Related]
18. Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: The battle between pro- and anti-inflammatory lipid mediators.
Gilbert NC; Newcomer ME; Werz O
Biochem Pharmacol; 2021 Nov; 193():114759. PubMed ID: 34487716
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.
Garscha U; Romp E; Pace S; Rossi A; Temml V; Schuster D; König S; Gerstmeier J; Liening S; Werner M; Atze H; Wittmann S; Weinigel C; Rummler S; Scriba GK; Sautebin L; Werz O
Sci Rep; 2017 Aug; 7(1):9398. PubMed ID: 28839250
[TBL] [Abstract][Full Text] [Related]
20. Macrophage Proresolving Mediators-the When and Where.
Dalli J; Serhan C
Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
